Cambian Group PLC (CMBN) Receives Consensus Rating of “Hold” from Analysts
Cambian Group PLC (LON:CMBN) has been given an average rating of “Hold” by the six analysts that are presently covering the company. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price objective among brokers that have covered the stock in the last year is GBX 104.67 ($1.28).
Several brokerages have recently weighed in on CMBN. Canaccord Genuity reiterated a “speculative buy” rating and set a GBX 95 ($1.16) target price on shares of Cambian Group PLC in a research report on Wednesday, September 14th. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 119 ($1.45) price target on shares of Cambian Group PLC in a report on Friday, July 15th. Finally, Numis Securities Ltd reissued an “add” rating and set a GBX 120 ($1.46) price target on shares of Cambian Group PLC in a report on Wednesday, October 5th.
Shares of Cambian Group PLC (LON:CMBN) traded up 0.42% during mid-day trading on Monday, reaching GBX 119.25. 156,794 shares of the company were exchanged. The firm has a 50-day moving average price of GBX 95.96 and a 200 day moving average price of GBX 71.51. The stock’s market capitalization is GBX 215.60 million. Cambian Group PLC has a 12 month low of GBX 48.25 and a 12 month high of GBX 290.00.
Cambian Group PLC Company Profile
Cambian Group plc is a provider of specialist behavioral health services for children and adults. The Company provides services to adults, which include specialist mental health services, acquired brain injury services and specialist residential care services. The services provided to children include specialist education services, specialist residential care services, foster care services and specialist mental health services.
Receive News & Stock Ratings for Cambian Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambian Group PLC and related stocks with our FREE daily email newsletter.